IDXX 147.18 Idexx Laboratories $IDXX Hit a 52 week
Post# of 36
Posted On: 11/10/2014 11:44:33 PM
IDXX 147.18 Idexx Laboratories $IDXX Hit a 52 week high of 147.67 Closing the day 11/10/14 at 147.18 +2.02 +1.39% With a day low of 144.18 and a total volume of 572,710.
IDXX Recent Posts: http://investorshangout.com/IDEXX-Laboratorie...DXX-54421/
IDXX Idexx Laboratories Recent Headline News
SmarTrend Watching for Potential Pullback in Shares of Idexx Laboratories After 1.39% Gain
Comtex SmarTrend(R) - Mon Nov 10, 5:17PM CST
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $144.18 to a high of $147.67. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $146.00 on volume of 560,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 147.18 (+2.02)
Idexx Laboratories Earnings Hindsight: Up 7.4% in Last 17 Days (IDXX)
Comtex SmarTrend(R) - Mon Nov 10, 1:31PM CST
17 days ago, on October 24th, 2014, Idexx Laboratories (NASDAQ:IDXX) reported its earnings. Analysts, on average, expected earnings of $0.86 per share on sales of $371.3 million. Idexx Laboratories actually reported earnings of $1.05 per share on sales of $383.5 million, beating EPS estimates by $0.19 and beating revenue estimates by $12.2 million. Since the company's report, shares of Idexx Laboratories have risen from $135.20 to $145.16, representing a gain of 7.4% in the past 17 days.
IDXX: 147.18 (+2.02)
Idexx Laboratories Has Returned 17.5% Since SmarTrend Recommendation (IDXX)
Comtex SmarTrend(R) - Wed Nov 05, 9:25AM CST
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on October 21st, 2014 at $122.52. In approximately 2 weeks, Idexx Laboratories has returned 17.52% as of today's recent price of $143.98.
IDXX: 147.18 (+2.02)
Comparing America's 3 Largest Diagnostic Substances Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 03, 12:03PM CST
QDEL: 28.02 (+0.15), NEOG: 44.29 (+1.28), IDXX: 147.18 (+2.02)
Quarterly Earnings Releases and Recognitions - Research Reports on GlaxoSmithKline, IDEXX, BioMarin, GE and Lockheed Martin
PR Newswire - Wed Oct 29, 8:30AM CDT
Today, Analysts Review released its research reports regarding GlaxoSmithKline plc (NYSE: GSK), IDEXX Laboratories, Inc. (NASDAQ: IDXX), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), General Electric Company (NYSE: GE) and Lockheed Martin Corporation (NYSE: LMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7542-100free.
LMT: 186.99 (+0.84), GE: 26.47 (+0.06), BMRN: 87.60 (+3.69), IDXX: 147.18 (+2.02), GSK: 45.16 (+0.25), NVS: 92.63 (+0.87)
IDEXX Laboratories (IDXX) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 7:57AM CDT
IDEXX Laboratories (IDXX) Shares March Higher, Can It Continue?
IDXX: 147.18 (+2.02)
IDEXX Tops Q3 Earnings and Revenues; Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:10PM CDT
Since the news release, IDEXX's (IDXX) share price has climbed 9.8% to eventually close at $138.76 yesterday.
ATEC: 1.42 (+0.03), EW: 124.60 (+1.84), IDXX: 147.18 (+2.02), ANGO: 16.96 (+0.01)
Today's Strong And Under The Radar Stock Is Idexx Laboratories (IDXX)
at The Street - Tue Oct 28, 8:51AM CDT
Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a strong and under the radar candidate
IDXX: 147.18 (+2.02)
IDEXX Laboratories, Inc. Is as Fit as a Butcher's Dog
Brian Orelli, The Motley Fool - Motley Fool - Fri Oct 24, 6:56PM CDT
Shares of IDEXX Laboratories jumped 7% today after reporting a solid third quarter, raising 2014 guidance, and issuing 2015 guidance that looks even better. The stock of the animal health-test provider soared to a 52-week and all-time high. ...
IDXX: 147.18 (+2.02)
Idexx Laboratories Set to Possibly Pullback After Yesterday's Rally of 7.00%
Comtex SmarTrend(R) - Fri Oct 24, 4:12PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $130.06 to a high of $140.42. Yesterday, the shares gained 7.0%, which took the trading range above the 3-day high of $126.42 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 147.18 (+2.02)
IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 1:02PM CDT
IDXX: 147.18 (+2.02)
Idexx Q3 income up 14%
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 10:00AM CDT
IDXX: 147.18 (+2.02)
Idexx beats Street 3Q forecasts
Automated Insights - Fri Oct 24, 6:27AM CDT
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported net income of $52.1 million in its third quarter.
IDXX: 147.18 (+2.02)
IDEXX Laboratories beats by $0.15, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 6:07AM CDT
IDXX: 147.18 (+2.02)
IDEXX Laboratories Announces Third Quarter Results
PR Newswire - Fri Oct 24, 6:00AM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported that revenues for the third quarter of 2014 increased 13% versus the prior year period to $384 million. Organic revenue growth1 for the third quarter of 2014 versus the prior year period was also 13%, or 11% normalized for changes in distributor inventory2. Earnings per diluted share ("EPS"
for the quarter ended September 30, 2014 increased 21% from the prior year period to $1.03. Adjusted EPS3 for the quarter was $1.05.
IDXX: 147.18 (+2.02)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 4:30PM CDT
WYN: 77.67 (+0.35), SFE: 20.10 (+0.32), F: 14.00 (-0.17), OCR: 68.73 (+0.76), B: 36.62 (+0.20), SXC: 23.37 (-0.30), VTR: 68.61 (+0.35), UPS: 109.05 (+0.72), DLPH: 69.87 (+0.28), CHH: 52.67 (-0.04), LYB: 88.03 (+0.57), COG: 33.20 (-0.42), SHPG: 200.98 (+2.40), TCB: 15.78 (+0.40), AVY: 48.04 (+0.30), AAN: 26.06 (+0.36), MGLN: 60.48 (+0.83), STT: 78.12 (+0.31), FNFG: 7.45 (+0.01), IMGN: 9.95 (+0.18), EDU: 21.66 (-0.69), BMY: 58.81 (+0.49), DTE: 83.85 (+0.54), LEA: 93.30 (+0.95), MCO: 99.32 (+0.37), FLIR: 33.21 (-0.57), IMS: 24.42 (-0.04), LPNT: 65.80 (+0.28), ERIC: 11.62 (-0.18), PG: 89.45 (+0.32), IDXX: 147.18 (+2.02), WBC: 102.03 (+0.05), NDAQ: 44.03 (+0.15), CL: 68.55 (+0.50)
Oracle Enterprise Manager Enables Seamless IT Management and Visibility for IDEXX Laboratories
Marketwired - Wed Oct 15, 7:04AM CDT
Oracle (NYSE: ORCL)
IDXX: 147.18 (+2.02), ORCL: 40.45 (+0.51)
IDEXX Laboratories to Release 2014 Third Quarter Financial Results
PR Newswire - Tue Oct 14, 12:45PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2014 third quarter financial results for Friday, October 24, 2014 at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
IDXX: 147.18 (+2.02)
IDEXX Laboratories Poised on Strong CAG Growth Globally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 5:40PM CDT
On Oct 7, 2014, we updated our research report on IDEXX Laboratories, Inc. (IDXX).
HNSN: 0.75 (-0.08), EW: 124.60 (+1.84), IDXX: 147.18 (+2.02), HOLX: 26.55 (+0.34)
Idexx Laboratories (IDXX) Marked As A Barbarian At The Gate
at The Street - Wed Oct 01, 2:02PM CDT
Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
IDXX: 147.18 (+2.02)
IDXX Recent Posts: http://investorshangout.com/IDEXX-Laboratorie...DXX-54421/
IDXX Idexx Laboratories Recent Headline News
SmarTrend Watching for Potential Pullback in Shares of Idexx Laboratories After 1.39% Gain
Comtex SmarTrend(R) - Mon Nov 10, 5:17PM CST
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $144.18 to a high of $147.67. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $146.00 on volume of 560,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 147.18 (+2.02)
Idexx Laboratories Earnings Hindsight: Up 7.4% in Last 17 Days (IDXX)
Comtex SmarTrend(R) - Mon Nov 10, 1:31PM CST
17 days ago, on October 24th, 2014, Idexx Laboratories (NASDAQ:IDXX) reported its earnings. Analysts, on average, expected earnings of $0.86 per share on sales of $371.3 million. Idexx Laboratories actually reported earnings of $1.05 per share on sales of $383.5 million, beating EPS estimates by $0.19 and beating revenue estimates by $12.2 million. Since the company's report, shares of Idexx Laboratories have risen from $135.20 to $145.16, representing a gain of 7.4% in the past 17 days.
IDXX: 147.18 (+2.02)
Idexx Laboratories Has Returned 17.5% Since SmarTrend Recommendation (IDXX)
Comtex SmarTrend(R) - Wed Nov 05, 9:25AM CST
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on October 21st, 2014 at $122.52. In approximately 2 weeks, Idexx Laboratories has returned 17.52% as of today's recent price of $143.98.
IDXX: 147.18 (+2.02)
Comparing America's 3 Largest Diagnostic Substances Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 03, 12:03PM CST
QDEL: 28.02 (+0.15), NEOG: 44.29 (+1.28), IDXX: 147.18 (+2.02)
Quarterly Earnings Releases and Recognitions - Research Reports on GlaxoSmithKline, IDEXX, BioMarin, GE and Lockheed Martin
PR Newswire - Wed Oct 29, 8:30AM CDT
Today, Analysts Review released its research reports regarding GlaxoSmithKline plc (NYSE: GSK), IDEXX Laboratories, Inc. (NASDAQ: IDXX), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), General Electric Company (NYSE: GE) and Lockheed Martin Corporation (NYSE: LMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7542-100free.
LMT: 186.99 (+0.84), GE: 26.47 (+0.06), BMRN: 87.60 (+3.69), IDXX: 147.18 (+2.02), GSK: 45.16 (+0.25), NVS: 92.63 (+0.87)
IDEXX Laboratories (IDXX) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 7:57AM CDT
IDEXX Laboratories (IDXX) Shares March Higher, Can It Continue?
IDXX: 147.18 (+2.02)
IDEXX Tops Q3 Earnings and Revenues; Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:10PM CDT
Since the news release, IDEXX's (IDXX) share price has climbed 9.8% to eventually close at $138.76 yesterday.
ATEC: 1.42 (+0.03), EW: 124.60 (+1.84), IDXX: 147.18 (+2.02), ANGO: 16.96 (+0.01)
Today's Strong And Under The Radar Stock Is Idexx Laboratories (IDXX)
at The Street - Tue Oct 28, 8:51AM CDT
Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a strong and under the radar candidate
IDXX: 147.18 (+2.02)
IDEXX Laboratories, Inc. Is as Fit as a Butcher's Dog
Brian Orelli, The Motley Fool - Motley Fool - Fri Oct 24, 6:56PM CDT
Shares of IDEXX Laboratories jumped 7% today after reporting a solid third quarter, raising 2014 guidance, and issuing 2015 guidance that looks even better. The stock of the animal health-test provider soared to a 52-week and all-time high. ...
IDXX: 147.18 (+2.02)
Idexx Laboratories Set to Possibly Pullback After Yesterday's Rally of 7.00%
Comtex SmarTrend(R) - Fri Oct 24, 4:12PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $130.06 to a high of $140.42. Yesterday, the shares gained 7.0%, which took the trading range above the 3-day high of $126.42 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 147.18 (+2.02)
IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 1:02PM CDT
IDXX: 147.18 (+2.02)
Idexx Q3 income up 14%
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 10:00AM CDT
IDXX: 147.18 (+2.02)
Idexx beats Street 3Q forecasts
Automated Insights - Fri Oct 24, 6:27AM CDT
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported net income of $52.1 million in its third quarter.
IDXX: 147.18 (+2.02)
IDEXX Laboratories beats by $0.15, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 6:07AM CDT
IDXX: 147.18 (+2.02)
IDEXX Laboratories Announces Third Quarter Results
PR Newswire - Fri Oct 24, 6:00AM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported that revenues for the third quarter of 2014 increased 13% versus the prior year period to $384 million. Organic revenue growth1 for the third quarter of 2014 versus the prior year period was also 13%, or 11% normalized for changes in distributor inventory2. Earnings per diluted share ("EPS"
for the quarter ended September 30, 2014 increased 21% from the prior year period to $1.03. Adjusted EPS3 for the quarter was $1.05. IDXX: 147.18 (+2.02)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 4:30PM CDT
WYN: 77.67 (+0.35), SFE: 20.10 (+0.32), F: 14.00 (-0.17), OCR: 68.73 (+0.76), B: 36.62 (+0.20), SXC: 23.37 (-0.30), VTR: 68.61 (+0.35), UPS: 109.05 (+0.72), DLPH: 69.87 (+0.28), CHH: 52.67 (-0.04), LYB: 88.03 (+0.57), COG: 33.20 (-0.42), SHPG: 200.98 (+2.40), TCB: 15.78 (+0.40), AVY: 48.04 (+0.30), AAN: 26.06 (+0.36), MGLN: 60.48 (+0.83), STT: 78.12 (+0.31), FNFG: 7.45 (+0.01), IMGN: 9.95 (+0.18), EDU: 21.66 (-0.69), BMY: 58.81 (+0.49), DTE: 83.85 (+0.54), LEA: 93.30 (+0.95), MCO: 99.32 (+0.37), FLIR: 33.21 (-0.57), IMS: 24.42 (-0.04), LPNT: 65.80 (+0.28), ERIC: 11.62 (-0.18), PG: 89.45 (+0.32), IDXX: 147.18 (+2.02), WBC: 102.03 (+0.05), NDAQ: 44.03 (+0.15), CL: 68.55 (+0.50)
Oracle Enterprise Manager Enables Seamless IT Management and Visibility for IDEXX Laboratories
Marketwired - Wed Oct 15, 7:04AM CDT
Oracle (NYSE: ORCL)
IDXX: 147.18 (+2.02), ORCL: 40.45 (+0.51)
IDEXX Laboratories to Release 2014 Third Quarter Financial Results
PR Newswire - Tue Oct 14, 12:45PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2014 third quarter financial results for Friday, October 24, 2014 at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
IDXX: 147.18 (+2.02)
IDEXX Laboratories Poised on Strong CAG Growth Globally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 5:40PM CDT
On Oct 7, 2014, we updated our research report on IDEXX Laboratories, Inc. (IDXX).
HNSN: 0.75 (-0.08), EW: 124.60 (+1.84), IDXX: 147.18 (+2.02), HOLX: 26.55 (+0.34)
Idexx Laboratories (IDXX) Marked As A Barbarian At The Gate
at The Street - Wed Oct 01, 2:02PM CDT
Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
IDXX: 147.18 (+2.02)
(0)
(0)IDEXX Laboratories Inc (IDXX) Stock Research Links
Scroll down for more posts ▼